Genentech Partners with Ribometrix in US$1 B RNA Therapeutics Deal
By Michelle Liu
Pharma Deals Review: Vol 2021 Issue 1 (Table of Contents)
Published: 15 Jan-2021
DOI: 10.3833/pdr.v2021.i1.2584 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Highlighting its commitment to RNA therapeutics, Genentech has partnered with Ribometrix to develop RNA-targeted small molecule therapeutics against several targets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018